Tempus ECG-AF vs ElucidVivo A.3

Tempus ECG-AF is designed to integrate seamlessly into existing ECG platforms and EHRs without a dedicated user interface, minimizing disruption to clinical workflows. This approach offers a lower friction adoption compared to ElucidVivo A.3, which, while integrating with PACS/EMR, implies a separate software application with its own user interface.

ElucidVivo A.3 provides a more profound and predictive clinical insight through quantitative analysis of arterial plaque composition and stability, validated against histology, and deriving fractional flow reserve (FFRct). This enables advanced patient stratification and has demonstrated a 40% improvement in predictive accuracy for major adverse neurologic events, offering a higher level of impact on patient management compared to Tempus ECG-AF's risk stratification.

While Tempus ECG-AF has an established CMS reimbursement path, ElucidVivo A.3 has recently secured a Category I CPT code (75577) with a significantly higher national average payment amount ($1,012 for imaging centers/physician offices, $951 for hospital outpatient settings), effective January 1, 2026. This, coupled with widespread coverage from major public and private payors, provides a more transparent and attractive financial value proposition.

Tempus ECG-AF explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. ElucidVivo A.3's compliance is implied by its FDA clearance and intended use, but explicit statements regarding HIPAA and BAA are not provided in the available information, giving Tool A a clear advantage in demonstrating enterprise readiness.

ElucidVivo A.3 demonstrates greater innovation by offering highly specialized, quantitative analysis of arterial plaque composition and stability, including histological validation and the derivation of FFRct. This provides predictive insights for personalized atherosclerosis management, moving beyond traditional diagnostic assistance to a deeper understanding of disease pathology.

Tempus AI provides clear customer support channels, including phone and email, with specified operating hours, and mentions offering necessary manuals and forms. Elucid Bioimaging provides general contact information but lacks explicit details on dedicated customer support resources, operating hours, or comprehensive documentation, making Tempus ECG-AF's support framework more robust and transparent.